Prognostic factors in Hodgkin's disease

Area of Science:

• Oncology
• Hematology
• Clinical Epidemiology

Background:

• Hodgkin's disease treatment has evolved significantly over decades.
• Understanding prognostic factors is crucial for patient management and treatment planning.

Purpose of the Study:

• To analyze clinical and treatment data of 163 Hodgkin's disease patients treated between 1940-1971.
• To identify independent prognostic factors influencing survival and relapse in Hodgkin's disease.

Main Methods:

• Retrospective analysis of clinical records and treatment outcomes.
• Reclassification of lesions using the 1965 Rye classification criteria.
• Statistical evaluation of over 200 clinical and histological variables.

Main Results:

• Clinical stage, histological type, and presence of systemic symptoms were significant prognostic factors.
• Fever, anemia, and lymphocytopenia notably impacted survival rates.
• Relapse-free interval was a strong indicator of long-term prognosis; extent of relapse site did not significantly influence survival.

Conclusions:

• Clinical stage, histology, and systemic symptoms are critical for predicting Hodgkin's disease outcomes.
• Fever, anemia, and lymphocytopenia are adverse prognostic indicators.
• Relapse-free interval is vital for long-term prognosis assessment.